pending 2022 MX2025006351A
Treatment of MTRES1 Related Diseases and Disorders
Inventors: Gregory McInnes
Plain Language Summary
Compositions comprising oligonucleotides (siRNA or ASO) that target MTRES1 for treating conditions associated with MTRES1 gene mutations.
RNA Therapeutics